DRUG
NASDAQ · Biotechnology
Bright Minds Biosciences Inc
$71.62
-0.66 (-0.91%)
Open$72.36
Previous Close$72.28
Day High$74.54
Day Low$70.84
52W High$170.00
52W Low$33.01
Volume—
Avg Volume520
Market Cap1.09B
P/E Ratio—
EPS$-1.75
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
-62.4% upside
Current
$71.62
$71.62
Target
$26.95
$26.95
$16.82
$26.95 avg
$32.06
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 177.09M | 163.76M | 147.32M |
| Net Income | 34.74M | 43.56M | 40.99M |
| Profit Margin | 19.6% | 26.6% | 27.8% |
| EBITDA | 73.10M | 70.32M | 54.60M |
| Free Cash Flow | 20.82M | 31.20M | 18.21M |
| Rev Growth | -5.5% | +4.9% | +20.1% |
| Debt/Equity | 0.67 | 0.83 | 0.74 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |